Insiders Valneva Xetra

Equities

Market Closed - Xetra Other stock markets 16:35:37 31/05/2024 BST			5-day change	1st Jan Change
4.112 ^EUR	+2.24%		+5.33%	-13.41%

05-31	Valneva's Chikungunya Vaccine Gains Support From EU Regulator Committee	MT
05-31	EU regulator recommends use of Valneva's chikungunya vaccine	RE

Valneva Se Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer	05-21	CI
Valneva Names New Chief Scientific Officer	05-21	MT
Valneva appoints Scientific Director	05-21	CF
Valneva SE Announces Executive Changes	12-21	CI
Valneva Shareholders OK One-tier Governance Model; New Chair Appointed	12-21	MT
Valneva SE Announces Board Changes	11-15	CI
Inflation Concerns Weaken Exchange-Traded Funds, Equity Futures Premarket Thursday	07/09/23	MT
Valneva Se Appoints Kathrin U Jansen to Supervisory Board	21/06/23	CI
Valneva: CFO joins Sensorion	27/02/23	CF
Sensorion Names Former Valneva CFO to Same Role	27/02/23	MT
Vaccine Developer Valneva Appoints New Chief Commercial Officer	17/11/22	MT
ValnevaSE Appoints Dipal Patel as Chief Commercial Officer	17/11/22	CI
Valneva SE Announces Supervisory Board Member Appointments	24/06/22	CI
Valneva Announces Board Appointments	31/05/22	CI
Valneva Reports Higher 9-Month Revenue, Tightens Full-Year Outlook	18/11/21	MT
ValnevaSE Appoints Peter Buhler as Management Board Member	29/07/21	CI
ValnevaSE Appoints Vincent Dequenne as Senior Vice President Operations	06/07/21	CI
Valneva SE Announces Resignation of Thomas Casdagli from Supervisory Board	13/03/21	CI
Valneva SE Appoints Perry Celentano as Chief Operating Officer	11/01/21	CI
Valneva Announces Management Changes	06/08/20	CI

No results for this search